In breast cancer, triple-negative breast cancer (TNBC) is a complicated and aggressive subtype of breast cancer that lacks estrogen receptors, progesterone receptors, and HER2 amplification, making it difficult to target therapeutically. This evidence concerns the gene ESR1 and breast cancer.